![P1126 IMPACT OF SAFETY-RELATED DOSE REDUCTIONS AND DISCONTINUATIONS (SR-RD) ON SUSTAINED VIROLOGICAL RESPONSE (SVR) IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS RECEIVING PEGINTERFERON ALFA-2a/RIBAVIRIN: RESULTS FROM GUARD-C]()
P1126 IMPACT OF SAFETY-RELATED DOSE REDUCTIONS AND DISCONTINUATIONS (SR-RD) ON SUSTAINED VIROLOGICAL RESPONSE (SVR) IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS RECEIVING PEGINTERFERON ALFA-2a/RIBAVIRIN: RESULTS FROM GUARD-CFoster, G.R.; Coppola, C.; Curescu, M.; Derbala, M.; Esmat, G.; Ferenci, P.; Flisiak, R.; Lengyel, G.; Mangia, A.; Orlandini, A.; Reddy, K.R.; Rodriguez-Torres, M.; Shiffman, M.L.; Sporea, I.; Tallarico, L.; Ahlers, S.; Bakalos, G.; Wat, C.; Hassanein, T. · Journal of Hepatology · 2014